Get the Stockscreener App
2.0117
3.33%
-0.0883
Metagenomi Inc stock is traded at $2.0117, with a volume of 291.12K.
It is down -3.33% in the last 24 hours and up +20.12% over the past month.
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
See More
Previous Close:
$2.10
Open:
$2.1
24h Volume:
291.12K
Relative Volume:
0.48
Market Cap:
$75.20M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.74%
1M Performance:
+20.12%
6M Performance:
-18.15%
1Y Performance:
-42.98%
1-Day Range:
$1.98
$2.1496
1-Week Range:
$1.98
$2.32
52-Week Range:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
Name
Metagenomi Inc
Sector
Industry
Phone
(510) 871-4880
Address
5959 HORTON STREET, EMERYVILLE
Compare MGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
2.0117 | 83.36M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
384.39 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.23 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
671.14 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
294.82 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Initiated | H.C. Wainwright | Buy |
| May-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-05-24 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-24 | Initiated | Chardan Capital Markets | Buy |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Mar-05-24 | Initiated | Jefferies | Buy |
| Mar-05-24 | Initiated | TD Cowen | Outperform |
| Mar-05-24 | Initiated | Wells Fargo | Overweight |
View All
Metagenomi Inc Stock (MGX) Latest News
Metagenomi Sells The Gene-Editing Dream—But Risk Looms Large - Finimize
How does Metagenomi Inc. compare to its industry peersTremendous return rates - Jammu Links News
When is Metagenomi Inc. stock expected to show significant growthBreakneck growth rates - Jammu Links News
Published on: 2025-08-04 03:23:40 - Jammu Links News
Should I hold or sell Metagenomi Inc. stock in 2025Outstanding stock performance - Jammu Links News
Metagenomi Inc. Stock Analysis and ForecastGet real-time alerts on top-performing stocks - Jammu Links News
Is it the right time to buy Metagenomi Inc. stockOutstanding capital returns - Jammu Links News
How many analysts rate Metagenomi Inc. as a “Buy”High-performance investment picks - Jammu Links News
What catalysts could drive Metagenomi Inc. stock higher in 2025Double-digit growth - Jammu Links News
What analysts say about Metagenomi Inc. stockHigh-return market picks - jammulinksnews.com
How volatile is Metagenomi Inc. stock compared to the marketMarket-crushing stock picks - Jammu Links News
What is Metagenomi Inc. company’s growth strategyAchieve rapid capital gains with smart investing - Jammu Links News
Is Metagenomi Inc. stock overvalued or undervaluedRapidly growing investment returns - Jammu Links News
How strong is Metagenomi Inc. company’s balance sheetPowerful market insights - Jammu Links News
How does Metagenomi Inc. generate profit in a changing economyGet professional advice for portfolio optimization - Jammu Links News
Is Metagenomi Inc. a growth stock or a value stockExceptional trading results - Jammu Links News
Discover People are buying the wrong stock thinking it's part of OpenAI's Stargate Project - Quartz
What are analysts’ price targets for Metagenomi Inc. in the next 12 monthsInvest in high-yield stocks with confidence - Jammu Links News
Analyzing Metagenomi Inc. with risk reward ratio chartsFree Investment Playbook for Growing Markets - Newser
What is the risk reward ratio of investing in Metagenomi Inc. stockSmart Portfolio Data Feed For 2025 - Jammu Links News
Metagenomi Inc. stock trendline breakdownMomentum Entry Alerts with Risk Control - Newser
What makes Metagenomi Inc. stock price move sharplyCommunity Entry Consensus Trade Ideas Shared - metal.it
How Metagenomi Inc. stock performs during market volatilitySector-Wise Stock Strength Trend Analysis - Newser
Will Metagenomi Inc. stock benefit from AI tech trendsRisk Adjusted Technical Entry Plan Gains Followers - metal.it
Price momentum metrics for Metagenomi Inc. explainedProfit Target Stock Opportunity Monitor Activated - metal.it
Metagenomi (MGX) Presents Latest in Gene Editing Technologies - Insider Monkey
Metagenomi Advances Gene Editing Technologies with Presentations at ASGCT Meeting - AInvest
Is Metagenomi Inc. Stock a Good Fit for Conservative InvestorsWeekly Market Direction and Sector Summary - Newser
Metagenomi Inc. Stock Support and Resistance Levels You Should KnowFree Real Market Momentum Signal Generator - Newser
Is Metagenomi Inc. building a consolidation baseAsset Growth Pattern and Return Summary - Newser
Will Metagenomi Inc. stock benefit from AI tech trends Fundamental + Technical Combined Watchlist - Newser
Why is Metagenomi Inc. stock attracting strong analyst attentionUnlock powerful trading signals for profits - Jammu Links News
Metagenomi Inc Stock (MGX) Financials Data
There is no financial data for Metagenomi Inc (MGX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metagenomi Inc Stock (MGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wein Matthew | See Remarks |
Jun 06 '25 |
Sale |
1.75 |
199 |
348 |
16,693 |
| Noonberg Sarah B. | Chief Medical Officer |
Jun 06 '25 |
Sale |
1.75 |
5,239 |
9,168 |
109,135 |
| Wapnick Pamela | Chief Financial Officer |
Jun 06 '25 |
Sale |
1.75 |
1,576 |
2,758 |
72,108 |
| Thomas Brian C. | Chief Executive Officer |
Jun 06 '25 |
Sale |
1.75 |
10,785 |
18,874 |
2,517,491 |
| Irish Jian | See Remarks |
Jun 06 '25 |
Sale |
1.75 |
6,390 |
11,182 |
315,543 |
| Wein Matthew | See Remarks |
Mar 05 '25 |
Sale |
1.87 |
930 |
1,744 |
9,467 |
| Wapnick Pamela | Chief Financial Officer |
Mar 05 '25 |
Sale |
1.87 |
1,808 |
3,390 |
59,684 |
| Wapnick Pamela | Chief Financial Officer |
Dec 05 '24 |
Sale |
1.86 |
1,559 |
2,900 |
61,492 |
| Wapnick Pamela | Chief Financial Officer |
Sep 05 '24 |
Sale |
2.88 |
6,265 |
18,043 |
63,051 |
0.36%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):